AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Clinical trial NCT06137118 · RECRUITING

Trial details

NCT number: NCT06137118
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia (B-ALL)

Start date: 2023-12-29
Primary completion: 2026-11-13
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.